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Abstract
Introduction
Evaluations of weight management programs in real-
world  settings  are  lacking.  The  RE-AIM  model  (reach, 
effectiveness,  adoption,  implementation,  maintenance) 
was  developed  to  address  this  deficiency.  Our  primary 
objective was to evaluate a 12-week insurance-sponsored 
weight  management  intervention  by  using  the  RE-AIM 
model,  including  short-term  and  long-term  individual 
outcomes  and  setting-level  implementation  factors.  Our 
secondary objective was to critique the RE-AIM model and 
its revised calculation methods.
Methods
We created operational definitions for components of the 
5 RE-AIM indices and used standardized effect size values 
from various statistical procedures to measure multiple 
components or outcomes within each index. We used χ2 
analysis to compare categorical variables and repeated-
measures analysis of variance to assess the magnitude of 
outcome changes over time.
Results
On the basis of data for 1,952 participants and surveys 
completed by administrators at 23 sites, RE-AIM indices 
ranging from 0 to 100 revealed low program reach and 
adoption  (5.4  and  8.8,  respectively),  moderate  effective-
ness (43.8), high implementation (91.4), low to moderate 
individual maintenance (21.2), and moderate to high site 
maintenance (77.8). Median (interquartile range) weight 
loss was 13 lb (6.5-21.4 lb) among participants who com-
pleted phase I (12 weeks; 76.5%) and 15 lb (6.1-30.3 lb) 
among those who completed phase II (1 year; 45.7%).
Conclusions
This program had a significant, positive effect on partici-
pants and has been sustainable but needs to be expanded 
for more public health benefit. The RE-AIM model pro-
vided a useful framework to determine program strengths 
and  weaknesses  and  to  present  them  to  the  insurance 
agency and public health decision makers.
Introduction
Regardless of the success of diet and physical activity 
programs  in  controlled  research  settings  (1-6),  if  large-
scale  programs  are  not  effective  or  easily  implemented 
in  real-world  settings  they  fall  short  of  their  intended 
purpose. In the Strategic Plan for NIH Obesity Research, 
the National Institutes of Health Obesity Research Task 
Force (7) outlined a national strategy for obesity research 
emphasizing the use of translational research. However, 
evaluation of the translation of effective programs to real-
world settings is lacking (8).
The  RE-AIM  model  (9)  was  developed  as  a  tool  to 
evaluate  health  promotion  programs  along  5  dimen-
sions: reach, effectiveness, adoption, implementation, and 
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
  www.cdc.gov/pcd/issues/2010/may/09_0114.htm • Centers for Disease Control and Prevention  1
Christiaan G. Abildso, PhD, MPH; Sam J. Zizzi, EdD; Bill Reger-Nash, EdDVOLUME 7: NO. 3
MAY 2010
2  Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2010/may/09_0114.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
maintenance. Reach refers to the percentage of potential 
participants  who  enroll  and  their  representativeness  of 
the  target  population;  effectiveness,  to  the  changes  in 
participant outcomes during the program; adoption, to the 
number and representativeness of sites willing to conduct 
the  program;  implementation,  to  site  adherence  to  pro-
gram protocols; and maintenance, to individual outcomes 
after final intervention contact and program continuation 
at sites over the long term (8-10).
The RE-AIM model has been used to evaluate a limited 
number of programs, including 14 WISEWOMAN cardio-
vascular screening interventions in North Carolina (11), 
a  church-based  physical  activity  intervention  in  South 
Carolina (12), and 2 diabetes self-management interven-
tions (13). To our knowledge, no evaluation of a large-scale 
weight  management  program  using  RE-AIM  methods 
has been published, but studies have shown the model is 
applicable to a variety of health behaviors and programs. 
Additionally, researchers have recommended revising RE-
AIM index calculation methods to reduce the likelihood of 
difficult-to-interpret negative values (13).
Our primary objective was to use RE-AIM to evaluate 
a  multisite,  insurance-sponsored  weight  management 
program that produced positive short-term physical and 
psychosocial changes in participants in a university labo-
ratory  setting.  Our  secondary  objective  was  to  critique 
the RE-AIM model’s usefulness as an evaluation tool for 
health promotion programs. We analyzed 3- and 12-month 
participant outcomes and site-level program implementa-
tion information.
Methods
This  study  evaluated  a  weight  management  program 
that has been offered since 2004 by a large public employ-
ees’ insurance agency in West Virginia as a benefit to its 
members. Obese insured members (body mass index [BMI] 
≥30 kg/m2) are eligible for the program, as are overweight 
members  (BMI  25.0-29.9  kg/m2)  who  also  report  being 
treated  for  hypertension,  diabetes,  heart  disease,  meta-
bolic syndrome, or sleep apnea. Participants enroll in the 
program by calling the insurance agency to be screened 
for height, weight, and health information and must have 
written approval from their primary care physician.
The  insurance  agency  also  screens  site  providers  to 
ensure  the  site  has  adequate  safety  devices,  exercise 
equipment,  and  staffing  to  accommodate  high-risk  par-
ticipants. At the time of this study, the insurance agency 
had approved 31 fitness facilities (“sites”) to accept par-
ticipants:  2  housed  in  university  cardiac  rehabilitation/
exercise  physiology  laboratories,  2  in  physical  therapy 
facilities, 5 in hospitals, and 22 private wellness/fitness 
centers. Searches of available print (14) and online (www.
wvha.com,  www.yellowpages.com)  resources  yielded  352 
of these types of facilities in West Virginia. Each approved 
site is required to designate an administrator to act as liai-
son with the insurance agency, handle participant contact, 
coordinate site services, and enter participant data into a 
database.
The  weight  management  program  evaluated  in  this 
study is a 1-year benefit, during which weight loss is pro-
moted by using a combination of behavior therapy (eg, food 
logs), individualized site-based exercise programming, and 
individualized  diet  therapy.  Case  management  nurses 
track participant progress on the basis of monthly entry of 
the following body measurements by the sites into a Web-
based  database:  weight  and  BMI,  systolic  and  diastolic 
blood pressure, body fat percentage, waist circumference, 
and number of site visits. Each site determines its mea-
surement protocols on the basis of available instruments 
and  staff  training.  Sites  are  compensated  via  monthly 
member copayments and insurance agency payments for 
the provision of on-site services in 2 phases.
Phase I (months 1-3)
Services provided during phase I include 1) access to 
the exercise site, 2) a 60-minute fitness evaluation and 
exercise program designed by an exercise physiologist, 3) 
a 60-minute evaluation and nutrition program designed 
by a registered dietitian, 4) monthly 30-minute exercise 
sessions  with  a  personal  trainer,  and  5)  60-minute  fol-
low-up  reassessments  by  the  exercise  physiologist  and 
registered dietitian at the end of month 3. Participants 
may be removed from the program if they fail to exercise 
at the site at least twice per week; turn in food logs peri-
odically; attend appointments with the exercise physiolo-
gist, registered dietitian, or personal trainer; or have body 
measurements  taken  by  site  staff  monthly.  Phase  I  is 
considered the “intervention” period for this evaluation. 
If participants meet the behavioral requirements and lose 
12 lb (or show substantial improvements in other physical 
measures) they may continue to phase II.VOLUME 7: NO. 3
MAY 2010
  www.cdc.gov/pcd/issues/2010/may/09_0114.htm • Centers for Disease Control and Prevention  3
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the 
Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and 
does not imply endorsement by any of the groups named above.
Phase II (months 4-12)
Phase II spans the remainder 
of the first year (9 months). This 
phase is considered the postint-
ervention period for the current 
evaluation  because  it  is  more 
like a private gym membership 
than a weight-loss intervention; 
it provides access to the facility 
and 1 personal training session 
per  month.  Participants  are 
expected to continue exercising 
at  the  facility  twice  per  week 
and  have  physical  measure-
ments and visit data submitted 
monthly by the sites to main-
tain the benefit.
The  insurance  agency  dic-
tates what services are offered, 
but  not  how  the  services  are 
implemented.  The  use  of  rel-
evant  weight  management 
guidelines  of  the  American 
College  of  Sports  Medicine 
(ACSM) (15) and the American 
Dietetic Association (16) is sug-
gested. For example, the exer-
cise physiologist may choose from fitness testing methods 
recommended by ACSM (eg, 6-minute walk test, 1-mile 
walk test) and the registered dietitian may use his or her 
discretion in diet composition or outcome goals.
Data sources
We used archival participant data and site administra-
tor surveys to evaluate the weight management program. 
The  insurance  agency  granted  us  access  to  an  online 
password-protected database containing demographic and 
physical measurement data of all program participants. 
The university’s institutional review board approved the 
study for the protection of human participants. We down-
loaded, verified, de-identified, and imported archival data 
of  all  participants  into  SPSS  version  14.0  (SPSS,  Inc, 
Chicago, Illinois).
To gather site-level program evaluation data, we recruit-
ed site administrators by mail, e-mail, and telephone (17) 
to complete an online survey. 
The  survey  assessed  1)  site 
staffing, equipment, and facil-
ities; 2) program implementa-
tion  methods;  and  3)  barri-
ers  to  program  implementa-
tion.  Section  2  of  the  survey 
was  relevant  to  this  study; 
it  included  items  that  ascer-
tained  the  procedures  (open-
ended) or frequency (categori-
cal) of conducting 14 program 
components during phase I as 
recommended  or  required  by 
the  insurance  agency:  mea-
suring  weight,  waist  circum-
ference,  body  fat  percentage, 
and blood pressure; providing 
individualized  nutrition  and 
fitness assessments, nutrition 
classes,  fitness  plan,  one-on-
one personal training, and fol-
low-up  nutrition  and  fitness 
assessments; tracking partici-
pant attendance; and review-
ing  home  exercise  and  food 
logs  or  journals.  Responses 
were  recoded  to  dichotomous 
variables (yes/no) and the sum 
of yes responses tallied to represent the number of pro-
gram components implemented.
Statistical analyses of RE-AIM indices
Presenting  results  using  the  RE-AIM  model  first 
requires creating operational definitions for multiple com-
ponents in each of the 5 RE-AIM dimensions (10) (Box). 
These components were used to calculate RE-AIM indices 
(Appendix).  Index  calculations  used  standardized  effect 
size  (18)  values  from  various  statistical  procedures  to 
measure multiple components or outcomes in each index. 
We  used  χ2  analysis  to  compare  categorical  variables 
and repeated measures analysis of variance (ANOVA) to 
assess the magnitude of outcome changes over time. In 
the indices, “positive” effects were reduced by differential 
or “negative” effects (eg, program attrition). This index 
calculation  method  has  resulted  in  negative  values  in 
prior studies (13) for 2 reasons. First, in calculating index 
values, differential effects have been subtracted directly 
Box. RE-AIM Components and Operational Definitions
RE-AIM Component Definition
Individual participation 
rate (IPR)
The percentage of eligible members of the 
insurance agency who participated in the 
weight management program
Demographic repre-
sentativeness (DR)
How well participants represented the 
population eligible for the program
Individual completion 
rate (ICR)
The percentage of participants who com-
pleted each of the phases of the weight 
management program
Outcomes (O) Weight change experienced by completers 
of each phase of the weight management 
program
Differential impact (DI) A measure of differential changes in 
weight experienced among phase I and II 
completers by sex and age
Setting participation 
rate (SPR)
The percentage of eligible cardiac reha-
bilitation centers, physical therapy clinics, 
wellness/fitness centers, and health clubs 
in the state that participated in the weight 
management program
Component implemen-
tation rate (CIR)
The percentage of program protocols 
implemented at each site
Setting continuation 
rate (SCR)
The percentage of program sites that 
have elected to continue conducting the 
program for more than 1 yearVOLUME 7: NO. 3
MAY 2010
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from outcome effects, overstating the “negative” program 
effect. To limit this potential distortion, we calculated a 
“proportion of positive effect not explained by differential 
effects” by first subtracting the differential (“negative”) 
effect size from 1 and then multiplying the difference by 
the “positive” effect (Appendix). Second, a negative index 
value may still result if the effect size is more than 1. 
We resolved this challenge by using effect size measures 
whose upper limit was 1.
Effect size measures (and interpretation) included the 
squared Cramer phi (φc
2) for χ2 tests (small [φc
2 ≈ .01], 
moderate [φc
2 ≈ .09], or large [φc
2 > .25]) and the squared 
curvilinear correlation coefficient (partial eta squared; η2) 
for ANOVA (small [η2 ≈ .01], moderate [η2 ≈ .06], or large 
[η2 > .14]) (18,19). All raw index scores ranging from 0 to 
1 were multiplied by 100 for summary index values of 0 
to 100. Missing data were excluded from analyses, which 
were conducted by using SPSS version 14.0.
Results
The data for 1,952 participants from 31 sites were export-
ed, and administrators from 27 of 31 active sites (87.1% 
response rate) completed online surveys. Responses from 4 
new sites whose participants had not yet completed phase 
I of the program were excluded from analysis, resulting 
in 23 completed site administrator surveys. The distribu-
tion of most of the participants’ measurement data was 
skewed, and data are presented as median (interquartile 
range) unless otherwise noted.
Individual-level impact ([reach * effectiveness] / 100)
A total of 60,041 adult members were covered by the 
insurance agency (N. Henderson, health promotions direc-
tor, written communication, January 2008). By using the 
state obesity (31%) and overweight (36%) prevalence rates 
(20), and national prevalence of overweight adults with at 
least 1 comorbid condition (66%) (21), we estimated that 
32,878  insurance  members  may  have  been  eligible  for 
the program. At the time of data collection, 1,952 mem-
bers had participated (5.9% individual participation rate) 
(Table 1).
Baseline  physical  measurements  for  men  and  women 
are presented in Table 2. A significantly larger percentage 
of participants than the eligible population were women 
(80.0% vs 54.1%; P < .001, φc
2 = .073), and more of them 
were aged 45-54.9 years and fewer of them were aged 65 
years or older (P < .001, φc
2 = .113), yielding a reach value 
(R) of 5.4 (Table 1).
Phase I outcome changes are presented in Table 3. Of 
1,647 participants who could have completed phase I (those 
who had started the program at least 12 weeks before data 
collection), 76.5% had done so. Fewer women (74.8%) than 
men (83.7%) completed phase I (P = .001, φc
2 = .007), and 
completion rates tended to rise with age. Participants who 
completed phase I had significant weight loss (13 lb [6.5-
21.4 lb]; P < .001, η2 = .592), and men lost significantly 
more weight than women (P < .001, η2 = .050). Differences 
in weight loss were also revealed among age groups (P = 
.003, η2= .014). These components produced an effective-
ness value (E) of 43.8 and an individual-level impact ([R * 
E] / 100) of 2.4 (Table 1).
Setting-level impact ([adoption * implementation] / 100)
There were 31 active weight management program sites 
out of a total of 352 potential sites in West Virginia at the 
time of data collection, resulting in an adoption value (A) 
of 8.8 (Table 1). Site survey responses (N = 23) showed 
that sites implemented a mean of 12.8 (standard devia-
tion [SD] 1.0) of 14 program components during phase I. 
All sites measured weight, waist circumference, body fat 
percentage, and blood pressure; tracked attendance; and 
provided initial and follow-up nutrition assessments with 
a registered dietitian, nutrition classes designed by the 
registered  dietitian,  and  an  individualized  exercise  pre-
scription. The least frequently implemented component, 
by 15 sites (65%), was having participants maintain home 
exercise  logs.  Implementation  survey  data  yielded  an 
implementation value (I) of 91.4 and a setting-level impact 
([A * I] / 100) of 8.0 (Table 1).
Long-term maintenance ([individual maintenance *  
setting maintenance] / 100)
Phase II outcome changes are presented in Table 4. Of 
762 participants who could have completed phase II (those 
who had started the program at least 1 year before data 
collection), 348 (45.7%) had done so (ICRPhII = .457) (Table 
1). Excluding the small samples of participants aged 18-
24.9 years (n = 2) and 65 years or older (n = 9), completion 
rates tended to increase with age and be higher in men 
in each age group. Participants who completed phase II VOLUME 7: NO. 3
MAY 2010
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achieved significant weight loss from baseline (15 lb [6.1-
30.3 lb]; P < .001, η2 = .467), shedding 6.7% (2.7%-12.7%) 
of baseline body weight. Weight loss was similar among 
phase II completers of different age groups (P = .61, η2 = 
.011) and between sexes (P = .21, η2 = .005). These values 
combined to yield an individual maintenance value (MI) of 
21.2 (Table 1).
Four of 18 sites (22%) that had been approved to accept 
participants at least 1 year before this study had stopped 
or had been disallowed to continue accepting participants, 
resulting in a setting maintenance value (MS) of 77.8 and 
a long-term maintenance value ([MI * MS] / 100) of 16.5 
(Table 1).
Discussion
We achieved our primary objective of using RE-AIM 
to  evaluate  a  weight  management  program.  We  found 
moderate  program  effectiveness  and  high  implementa-
tion,  suggesting  the  program  has  been  beneficial  for 
participants  and  can  be  implemented  in  a  variety  of 
settings. We found low program reach and adoption, sug-
gesting the program could be improved by recruiting new 
participants and sites. Recruitment may prove difficult, 
however, because participants must be highly motivated 
to enroll in the program, and sites are required to offer 
services  by  highly  trained  personnel  often  unavailable 
in rural areas of West Virginia. In the long term, site 
maintenance was high, but individual maintenance was 
fairly low, indicating the program is sustainable but the 
services of phase II may need to be revised to improve 
participant  outcomes.  The  summary  results  suggest 
this  weight  management  program  has  potential  to  be 
expanded for more translation and public health benefit 
and should be considered a viable model for other public 
and private insurers.
Individual short-term and long-term outcome changes 
are comparable with those of other behavioral programs 
and clinical trials. Short-term attrition from this weight 
management program (23.5%) was slightly higher than is 
commonly seen in behavioral programs of similar length 
(10%-15%), though the median weekly weight loss in this 
program is comparable (1.23 lb vs 1.1 lb) (22). This pro-
gram also compares favorably with clinical trials of simi-
lar length, which average 85%-95% completion rates and 
approximately 1 lb of weekly weight loss (1,5).
Long-term  individual  results  also  compare  favor-
ably with other behavioral programs and clinical trials. 
Participants who completed phase II (n = 348) lost a mean 
of 20.9 (SD, 22.3) lb from baseline, with some recidivism. 
Slightly more than half of phase II completers (51.5%) 
maintained phase I weight loss or continued losing weight 
in phase II. In comparison, approximately 60% to 70% of 
weight loss is maintained for a year after treatment in 
other short-term behavioral interventions (22). One-year 
results  indicate  more average  weight  losses  but  lower 
completion rates than randomized control trials of similar 
length (1,5).
We also achieved the secondary objective of critiquing 
the  RE-AIM  model  and  revised  index  calculations.  The 
strength of the RE-AIM model is its ability to quantify for 
decision makers a program’s strengths and weaknesses. 
Comparison with other health promotion program evalu-
ations that used RE-AIM is limited at this point in the 
model’s refinement because no 2 studies have used the 
same  index  calculation  methods.  We  believe  this  study 
advances the RE-AIM model by 1) providing methods for 
assessing  long-term  maintenance  at  the  individual  and 
site levels and 2) addressing 2 methodologic concerns with 
existing index calculation methods (ie, negative index val-
ues and effect sizes with varying maximum values). The 
revised methods in this study produced positive R and MI 
values, whereas previously used methods (10) would have 
yielded negative values.
Limitations
The  study  is  limited  in  a  number  of  ways.  Multiple 
sources  of  measurement  error  may  have  affected  the 
data,  including  1)  lack  of  standardized  procedures  and 
instruments for measuring health  outcomes, 2) missing 
outcome  data,  and  3)  social  desirability  of  sites  when 
entering  participant  data  and  completing  survey  items. 
Potential error was addressed in multiple ways. Trained 
exercise professionals took measurements using accepted 
professional standards of practice, the insurance agency 
periodically audited site data, we contacted sites to collect 
missing data, and all survey recruiting material stressed 
the  informative  (not  punitive)  nature  of  the  study  and 
independence  of  the  investigators  from  the  insurance 
agency. Measurement error would be more important in 
a small clinical trial assessing an intervention’s efficacy 
than in this study with its large sample and focus on stan-
dardized effect sizes.VOLUME 7: NO. 3
MAY 2010
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Conclusions
Numerous questions remain to be answered before the 
public health effect of this and other weight management 
programs can be better understood. This program had a 
significant positive effect on participants and was sustain-
able, but needs to be expanded. The RE-AIM model pro-
vided a framework through which the translation of this 
program could be evaluated and presented to public health 
decision makers. In fact, the summary data of this project 
were presented to the insurance agency and used as evi-
dence for changing the program benefit to address the low 
reach,  adoption,  and  long-term  individual  maintenance. 
We encourage continued study of RE-AIM index calcula-
tions  and  application  of  the  model  to  evaluate  obesity 
treatment programs. It may be beneficial to add qualita-
tive process data to these outcomes to work toward devel-
oping a set of best practices in behavioral weight manage-
ment  (11,12).  Additionally,  because  insurance  agencies 
often  provide  benefits  for  multiple  weight  management 
modalities (eg, behavioral, surgical, pharmacologic), RE-
AIM methods should be used to evaluate multiple modali-
ties concurrently to allow for side-by-side comparison and 
facilitate decision making about resource allocation. These 
evaluations  will  need  to  link  program  costs,  insurance 
claims, individual outcomes, and future cost savings. Such 
analyses may affect the benefit and incentive structure 
of this insurer and others to improve the translation of 
knowledge regarding clinical obesity treatment into inno-
vative programming that can be widely implemented.
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Tables
Table 1. RE-AIM Model Component and Index Values Used to Evaluate a Weight Management Program, West Virginia, 2004
Component RE-AIM Index Valuea
Individual participation rate (IPR)   IPR = 1,92 / 0,041 * (.31 + [.3 * .])
IPR = .09
Demographic representativeness (DR)   DR = (.073 + .113) / 2 
DR = .093
  Reach (R) R = (.059 * [1 – .093]) * 100 
 
R = 5.4
Phase I individual completion rate (ICRPhI)   ICRPhI = 1,20 / 1,47 
ICRPhI = .7
Phase I outcome (OPhI)   OPhI = .92
Phase I differential impact (DIPhI)   DIPhI = (.00 + .014) / 2 
DIPhI = .032
  Effectiveness (E) E = (.765 * .592 * [1 - .032]) * 100 
 
E = 43.8
Setting participation rate (SPR)   SPR = 31 / 32
SPR = .0
  Adoption (A) A = (.088 * 100) = 8.8
Component implementation rate (CIR)   CIR = 12. / 14 
CIR = .914
  Implementation (I) I = (.914 * 100) = 91.4
Phase II individual completion rate (ICRPhII)   ICRPhII = 34 / 72 
ICRPhII = .47
Phase II outcome (OPhII)   OPhII = .47
Phase II differential impact (DIPhII)   DIPhII = (.00 + .011) / 2 
DIPhII = .00
  Individual maintenance (MI) MI = (.457 * .467 * [1 - .008]) * 100 
 
MI = 21.2
Setting continuation rate (SCR)   SCR = 14 / 1 
SCR = .77
  Setting maintenance (MS) MS = (.778 * 100) = 77.8
 
Abbreviation: RE-AIM, reach, effectiveness, adoption, implementation, maintenance. 
a Methods of calculating the values are described in the Appendix.VOLUME 7: NO. 3
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Table 2. Baseline Measurements of Participants, Weight Management Program, West Virginia, 2004
Measurement
Women (n = 1,561) Men (n = 391)
No.a Median (IQR)b No.a Median (IQR)b
Age, y 1, 49.7 (41.7 to .) 391 1. (43.0 to 7.)
Height, in 1,7 4.0 (3.0 to .0) 390 71.0 (9.0 to 73.0)
Weight, lb 1,42 220. (192.0 to 2.4) 34 29.9 (232.7 to 333.)
BMI, kg/m2 1,42 3. (32. to 43.1) 33 37. (32. to 44.)
Systolic blood pressure, mm Hg 1,39 12.0 (11.0 to 13.0) 330 130.0 (120.0 to 140.0)
Diastolic blood pressure, mm Hg 1,39 0. (9.9)c 330 2.1 (9.)c
Body fat, % 1,193 4.9 (41.9 to 49.4) 302 3.1 (31. to 42.)
Waist, in 73 43.0 (3. to 47.) 22 47.4 (43. to 3.0)
 
Abbreviations: IQR, interquartile range; BMI, body mass index. 
a Sample sizes vary because of missing data for some measurements. 
b Median and IQR are presented for data with skewed distributions unless otherwise noted. 
c Measurement has a normal distribution and is presented as mean (standard deviation). 
Table 3. 12-Week Measurements and Changes From Baseline of Phase I Completers, Weight Management Program, West 
Virginia, 2004a
Measurement
Phase I Completers 
(n = 1,260, 76.5%)
End Phase I Change From Baseline
No.b Median (IQR)c No.b Median (IQR)c
Women (n = 993; 74.8% completion rate)
Weight, lb 971 20.4 (179.0 to 242.) 970 −12.0 (−19.8 to −6.0)
Weight, % NA NA 970 −5.5 (−8.7 to −2.8)
BMI, kg/m2 971 34. (30.9 to 40.0) 970 −2.1 (−3.3 to −1.0)
Systolic blood pressure, mm Hg 79 122.0 (113.0 to 130.0) 74 −5.0 (16.1)d
Diastolic blood pressure, mm Hg 79 77.1 (.9)d 74 −3.4 (10.5)d
Body fat, % 04 43. (39.7 to 47.9) 740 −2.0 (3.2)d
Waist, in 90 39.9 (3.0 to 44.0) 14 −2.5 (−4.1 to −1.5)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 1,47 participants could have completed phase I. 
b Sample sizes vary because of missing data for some measurements; negative change values indicate improvements from baseline to the end of phase I (12 
weeks). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
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Measurement
Phase I Completers 
(n = 1,260, 76.5%)
End Phase I Change From Baseline
No.b Median (IQR)c No.b Median (IQR)c
Men (n = 267; 83.7% completion rate)
Weight, lb 23 21. (219. to 30.) 23 −16.9 (−29.3 to −8.0)
Weight, % NA NA 23 −6.1 (−10.2 to −3.0)
BMI, kg/m2 23 3.1 (30. to 41.3) 22 −2.3 (−3.9 to −1.1)
Systolic blood pressure, mm Hg 223 124.0 (117.0 to 132.0) 213 −7.3 (13.6)d
Diastolic blood pressure, mm Hg 223 7.9 (.7)d 213 −4.6 (9.7)d
Body fat, % 214 33.0 (29.1 to 39.0) 199 −3.6 (4.9)d
Waist, in 199 4.0 (41.0 to 0.) 14 −2.5 (−4.4 to −1.3)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 1,47 participants could have completed phase I. 
b Sample sizes vary because of missing data for some measurements; negative change values indicate improvements from baseline to the end of phase I (12 
weeks). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
Table 4. One-Year Measurements and Changes From Baseline of Phase II Completers, Weight Management Program, West 
Virginia, 2004a
Measurements
Phase II Completers 
(n = 348, 45.7%)
End Phase II Change From Baseline
nb Median (IQR)c nb Median (IQR)c
Women (n = 257; 39.5% completion rate)
Weight, lb 21 19.0 (173.4 to 227.4) 21 −15.3 (−28.6 to −6.3)
Weight, % NA NA 21 −7.1 (−12.5 to −3.1)
BMI, kg/m2 21 32.7 (29. to 3.2) 21 −2.6 (−4.8 to −1.1)
Systolic blood pressure, mm Hg 199 123. (12.7)d 197 −5.3 (17.0)d
Diastolic blood pressure, mm Hg 199 7.7 (.)d 197 −6.3 (11.2)d
Body fat, % 21 42. (.0)d 1 −2.7 (4.5)d
Waist, in 193 3.0 (3.4 to 41.9) 113 −4.0 (−6.4 to 2.0)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 72 participants could have completed phase II. 
b Sample sizes vary because of missing data for some measures; negative change values indicate improvements from baseline to the end of phase II (1 year). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
Table 3. (continued) 12-Week Measurements and Changes From Baseline of Phase I Completers, Weight Management 
Program, West Virginia, 2004a
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Measurements
Phase II Completers 
(n = 348, 45.7%)
End Phase II Change From Baseline
nb Median (IQR)c nb Median (IQR)c
Men (n = 91; 51.4% completion rate)
Weight, lb  24. (217. to 29.2)  −14.8 (−36.3 to −5.2)
Weight, % NA NA  −5.4 (−12.9 to −1.8)
BMI, kg/m2  34. (30.1 to 39.)  −2.1 (−5.1 to −0.7)
Systolic blood pressure, mm Hg 7 12.7 (14.1)d  −7.1 (14.7)d
Diastolic blood pressure, mm Hg 7 7. (10.)d  −6.4 (10.4)d
Body fat, % 4 33.2 (.)d  −2.9 (6.6)d
Waist, in 0 43.3 (3. to 0.0) 37 −3.0 (−5.1 to −1.6)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 72 participants could have completed phase II. 
b Sample sizes vary because of missing data for some measures; negative change values indicate improvements from baseline to the end of phase II (1 year). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
Appendix. RE-AIM Components, Indices, and Calculation Equations
Component RE-AIM Index Calculation Equation
Individual participation rate (IPR)   No. of participants / no. of adult insurance agency members * (state’s adult obesity preva-
lence rate + [state’s adult overweight prevalence rate * overweight with at least 1 comor-
bid condition national prevalence rate])
Demographic representativeness 
(DR)
  Mean ES (φc
2) of sex- and age-bracket χ2 comparisons of program participants and state 
residents
  Reach (R) R = (IPR * [1 – DR]) * 100
Phase I individual completion rate 
(ICRPhI)
  No. of phase I completers / no. participants who could have completed phase I
Phase I outcome (OPhI)   ES (η2) from 1-way RM ANOVA (IV: time; DV: weight among phase I completers)
Phase I differential impact (DIPhI)   Mean ES (η2) from two 2-way RM ANOVAs: 1) IVs: time x age bracket; DV: weight among 
phase I completers, and 2) IVs: time x sex; DV: weight among phase I completers
  Effectiveness (E) E = (ICRPhI * OPhI * [1 – DIPhI]) * 100
Setting participation rate (SPR)   No. of active sites / (no. of cardiac rehabilitation centers + no. of physical therapy clinics + 
no. of hospitals + no. of wellness/fitness centers + no. of health clubs in the state)
 
Abbreviations: ES, effect size; φc
2, squared Cramer phi; η2, partial eta squared; RM ANOVA, repeated measures analysis of variance; IV, independent variable; 
DV, dependent variable.
Table 4. (continued) One-Year Measurements and Changes From Baseline of Phase II Completers, Weight Management 
Program, West Virginia, 2004a
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Component RE-AIM Index Calculation Equation
  Adoption (A) A = SPR * 100
Component implementation rate 
(CIR)
  Mean no. of “yes” responses to “Program Components” section of site survey / 14
  Implementation (I) I = CIR * 100
Phase II individual completion rate 
(ICRPhII)
  No. of phase II completers / no. of participants who could have completed phase II
Phase II outcome (OPhII)   ES (η2) from 1-way RM ANOVA (IV: time; DV: weight among phase II completers)
Phase II differential impact (DIPhII)   Mean ES (η2) from two 2-way RM ANOVAs: 1) IVs: time x age bracket; DV: weight among 
phase II completers, and 2) IVs: time x sex; DV: weight among phase II completers
  Maintenance: indi-
vidual (MI)
MI = (ICRPhII * OPhII * [1 – DIPhII]) * 100
Setting continuation rate (SCR)   No. of active sites that have continued to offer the program for 1 year or longer / no. of 
sites that started offering the program 1 year or more before study
  Maintenance: setting 
(MS)
MS = SCR * 100
 
Abbreviations: ES, effect size; φc
2, squared Cramer phi; η2, partial eta squared; RM ANOVA, repeated measures analysis of variance; IV, independent variable; 
DV, dependent variable.
Appendix. (continued) RE-AIM Components, Indices, and Calculation Equations